3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Head and Neck Neoplasms
4
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Ovarian Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Thoracic Diseases
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Rectal Neoplasms
1
Peritoneal Diseases
1
Paraproteinemias
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Diseases
1
Neuroblastoma
1
Nervous System Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mesothelioma, Malignant
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Interventions
Cyclophosphamide
6
Granulocyte Colony-Stimulating Factor
5
Melphalan
4
Etoposide
4
Cisplatin
4
Carboplatin
4
sodium thiosulfate
3
fludarabine
3
Thiotepa
3
Mesna
3
Filgrastim
3
Busulfan
3
pembrolizumab
2
Vorinostat
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Ifosfamide
2
Gemcitabine
2
Fluorouracil
2
Doxorubicin
2
talazoparib
1
sintilimab
1
sargramostim
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
lenvatinib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hepatoblastoma
×
Tissue Banks
×
Clear all
NCT00228683
2013-11-26
Hepatoblastoma Biology Study and Tissue Bank
Emory University
Phase NA
Withdrawn